Resources To Support The Safety Of Girls And Women Who Are Being Treated With Valproate

It is vital where valproate is prescribed to girls and women of childbearing potential that they are made aware of the risks of taking the medication in pregnancy. The need for effective contraception planning must also be emphasised, along with the requirement for specialist oversight to safely change their medication if planning a pregnancy. MHRA have updated its valproate toolkit, providing a range of resources to support providers, staff and patients in the safe use of valproate. This alert asks all providers to undertake systematic identification of girls and women who are taking valproate, and to ensure the MHRA resources are used to support them to make informed choices.

Patient Safety Alert – Resources to support safe use of valproate.pdf